ZD-0892 is a selective and poten neutrophil elastaset inhibitor(human neutrophil elastase and porcine pancreatic elastase with Kis of 6.7 and 200 nM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 2043 | |
10 mg | 6-8 weeks | $ 3473 | |
20 mg | 6-8 weeks | $ 5821 | |
50 mg | 6-8 weeks | $ 11921 | |
100 mg | 6-8 weeks | $ 18119 |
Description | ZD-0892 is a selective and poten neutrophil elastaset inhibitor(human neutrophil elastase and porcine pancreatic elastase with Kis of 6.7 and 200 nM, respectively). |
Targets&IC50 | Human neutrophil elastase:200 nM (ki), Human neutrophil elastase:ki: 6.7 nM |
In vivo | Administration of ZD0892 to DBA/2 mice infected with EMC virus can reduce the elastic dissolution activity of myocardium and coronary microvascular perfusion injury. ZD0892 decreases the pathologic severity of the myocardial lesions associated with murine viral myocarditis. ZD-0892 can reverse advanced pulmonary vascular disease produced in rats. |
CAS No. | 171964-73-1 |
Chemical Formula | C24H32F3N3O5 |
Molecular Weight | 499.531 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom